Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension (Q34535592)

2 August 2017

1 reference

title

Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension (English)

1 reference

2 August 2017

1 reference

1 reference

Pedrinelli R

1 reference

2 August 2017

Dell'Omo G

1 reference

2 August 2017

Di Bello V

1 reference

2 August 2017

Pontremoli R

1 reference

2 August 2017

Mariani M

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Journal of Human Hypertension

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

79-89

1 reference

Increased urinary albumin-excretion rate in benign essential hypertension.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Urinary albumin excretion and blood pressure in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria: associations with height and sex in non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Target Organ Status and Serum Lipids in Patients With White Coat Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Capillary hypertension and abnormal pressure dynamics in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Prognostic value of ambulatory blood pressure : current evidence and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Systolic blood pressure revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and hypertension in nondiabetic Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Association of microalbuminuria and atherosclerotic risk factors in non-diabetic subjects in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin, Sodium-Lithium Countertransport, and Microalbuminuria in Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin resistance and human disease: a short history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

The relationship of hyperinsulinemic state to left ventricular hypertrophy, microalbuminuria, and physical fitness in borderline and mild hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Dual effect of insulin on plasma volume and transcapillary albumin transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria: a genetic link between diabetes and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Albuminuria in association with insulin and sodium-lithium countertransport in young African Americans with borderline hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and erythrocyte sodium-hydrogen exchange in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and associated cardiovascular risk factors in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Dissociation between urinary albumin excretion and variables associated with insulin resistance in a healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin sensitivity in clinically healthy individuals with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Longitudinal Study of Associations of Microalbuminuria With the Insulin Resistance Syndrome and Sodium-Lithium Countertransport in Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Regional differences in albuminuria among American Indians: an epidemic of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Combined renal effects of overweight and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in never-treated hypertensives: lack of relationship to hyperinsulinemia and genetic predisposition to hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Albuminuria in normals and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Cigarette smoking, endothelial injury and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria is an early marker of target organ damage in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Prognostic implications of left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria, renal function and waist:hip ratio in black hypertensive Jamaicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Increased renal resistive index in patients with essential hypertension: a marker of target organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in hypertension: Is it up to measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in urban Zimbabwean women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Racial differences in the prevalence of microalbuminuria in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Regression of left ventricular hypertrophy by medical treatment: present status and possible implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Epidemiology of microalbuminuria in a French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and markers of the atherosclerotic process: the D.E.S.I.R. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

Microalbuminuria in Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Assessment of a new dipstick test in screening for microalbuminuria in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Multicenter Evaluation of the Micral-Test II Test Strip, an Immunologic Rapid Test for the Detection of Microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

LEFT VENTRICULAR MASS AND MICROALBUMINURIA: RELATION TO AMBULATORY BLOOD PRESSURE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population. The Bogalusa Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria precedes the development of NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

White coat hypertension and target organ involvement: the impact of different cut-off levels on albuminuria and left ventricular mass and geometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Relationship Between Ambulatory Blood Pressure and Albuminuria in Normal Subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Combination of enalapril and low-dose thiazide reduces normoalbuminuria in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in mild hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Transforming growth factor beta in hypertensives with cardiorenal damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Effects of lisinopril and nitrendipine on urinary albumin excretion and renal function in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Forearm blood flow reserve and cardiac and renal indexes of pressure load in normotensive and hypertensive individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria is associated with abnormal thoracic aortic mechanics in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria and transcapillary albumin leakage in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Dissociation between microalbuminuria and common carotid thickness in essential hypertensive men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Arterial hypertension, microalbuminuria, and risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Atherosclerosis profile and microalbuminuria in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Dissociation between albuminuria and insulinaemia in hypertensive and atherosclerotic men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Hypertensive nephropathy and the gene for angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

ACE gene polymorphism explains 30-40% of variability in serum ACE activity in both women and men in the population at large: the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Urinary albumin excretion in smokers and non-smokers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria and endothelial dysfunction in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Left ventricular geometry and function in patients with essential hypertension and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria and renal haemodynamics in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Nephroprotective effect of antihypertensive drugs in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria does not predict cardiovascular disease in a normal general practice population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. The Copenhagen City Heart Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Albuminuria in aborigines and Europids of south-eastern Australia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001316

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001316

1 reference

Dimensions Publication ID

2 August 2017

1027260331

0 references

1 reference